Patent · US Active

Compounds for treatment of cancer

US8822513B2 · kind B2 · utility

20Cited by

4References

36Claims

0Family size

Assignees

GTX Corp · US
University of Tennessee Research Foundation · US

Inventors

Yan Lu · Mountain View, US
Chien-Ming Li · Fremont, US
Zhao Wang · Memphis, US
Jianjun Chen · Lund, SE
Wei Li · Lexington, US
James T. Dalton · Columbus, US
Duane D. Miller · Germantown, US
Charles B. Duke · Memphis, US
Sunjoo Ahn · Daejeon, KR

Key dates

Filing date	Aug 24, 2011
Grant date	Sep 2, 2014
Priority date	—
Expiry date	Jan 20, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to novel compounds having anti-cancer activity, methods of making these compounds, and their use for treating cancer and drug-resistant tumors, e.g. melanoma, metastatic melanoma, drug resistant melanoma, prostate cancer and drug resistant prostate cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.